MedTrace Logo

Acceptability Study on Oral Nutrition Supplement (ONS)

NCT02538250 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2016-10-13

No results posted yet for this study

Summary

Required for Advisory Committee for Borderline Substances (ACBS) approval. Aim of this study is to access the palatability, compliance and GI-tolerance of Nutricomp® Drink Plus to show that it is acceptable for patients in the United Kingdom.

Conditions

  • Oral Nutritional Supplementation

Interventions

DIETARY_SUPPLEMENT

Nutricomp Drink Plus

Oral nutritional supplementation

Sponsors & Collaborators

  • B. Braun Medical UK Ltd.

    lead INDUSTRY

Principal Investigators

  • David Sanders, Prof. · The Royal Hallamshire Hospital,Regional Gastrointestinal and Liver Unit, Sheffield, UK

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02538250 on ClinicalTrials.gov